Kanuma
Drug Immunology
NDC 25682-007-01
General payments
$107,928
Research payments
$48,353
Through program year 2021, $107,928 in general payments and $48,353 in research payments were reported against Kanuma (Immunology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $13,550 | 9 |
| 2020 | General | $10,817 | 30 |
| 2019 | General | $83,561 | 1,002 |
| 2019 | Research | $48,353 | 12 |
Breakdown
Each share is of general payments naming this product in 2021.
Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2021 where a state was reported.
Records
1,041 general · 12 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.